{"date":"2025-03-09","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6892-2025-03-09-1036-qobz1c","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-09","time":"10:36:28","subject":"本公司接獲衛生福利部對美國子公司PhiBio TherapeuticsInc.自體細胞新藥TRK-001臨床試驗計畫之GTP訪查觀察紀錄缺失，本公司將於1個月內回覆補正說明","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-09 10:36，「本公司接獲衛生福利部對美國子公司PhiBio TherapeuticsInc.自體細胞新藥TRK-001臨床試驗計畫之G」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}